Tag: Finch Therapeutics Group Inc.

Analysts Viewpoint

Finch Therapeutics Group Inc’s recent filing unveils that its Director SMISEK JEFFERY A unloaded Company’s shares for reported $17070.0 on

Stock Earnings

In a filing, Finch Therapeutics Group Inc revealed its Director SMISEK JEFFERY A unloaded Company’s shares for reported $17070.0 on